BIO: Big Pharma offers menu of partnering options, but biotechs want licensing entrée

Eli Lilly’s Renee Williams arrived in New York City this week ready to mix and mingle with dozens of biotechs that had descended on the Big Apple itching to strike a deal. | With few avenues available to budding biotechs looking for funding, the pressure to ink licensing agreements was palpable at the Biotechnology Innovation Organization’s CEO and Investor Conference in New York.